Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECISE-MRI
NL-OMON47608Phase 2Active, not recruiting
- Sponsor
- University Hospital Basel
- Start
- Dec 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in carotid atheroma (CAS) comparing Ticagrelor plus aspirin with Clopidogrel plus aspirin (2 arms). Primary endpoint: Presence of at least one new ischemic brain lesion on MRI after carotid artery stenting. Started Dec 2017; status: active, not recruiting.
02
Drugs
ticagrelorclopidogrelaspirin
03
Conditions
carotid atheroma (CAS)
Beyond the preview
Go deeper on NL-OMON47608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47608.